NAGIOS: RODERIC FUNCIONANDO

Salivary levels of Tumour Necrosis Factor-alpha in patients with recurrent aphthous stomatitis

Repositori DSpace/Manakin

IMPORTANT: Aquest repositori està en una versió antiga des del 3/12/2023. La nova instal.lació está en https://roderic.uv.es/

Salivary levels of Tumour Necrosis Factor-alpha in patients with recurrent aphthous stomatitis

Mostra el registre parcial de l'element

dc.contributor.author Eguía Del Valle, Asier es
dc.contributor.author Martínez-Conde Llamosas, Rafael es
dc.contributor.author López Vicente, José es
dc.contributor.author Uribarri Etxebarria, Agurne es
dc.contributor.author Aguirre Urízar, José Manuel es
dc.date.accessioned 2017-07-27T06:48:21Z
dc.date.available 2017-07-27T06:48:21Z
dc.date.issued 2011 es
dc.identifier.citation Eguía Del Valle, Asier ; Martínez-Conde Llamosas, Rafael ; López Vicente, José ; Uribarri Etxebarria, Agurne ; Aguirre Urízar, José Manuel. Salivary levels of Tumour Necrosis Factor-alpha in patients with recurrent aphthous stomatitis. En: Medicina oral, patología oral y cirugía bucal. Ed. inglesa, 16 1 2011: 8- es
dc.identifier.uri http://hdl.handle.net/10550/60194
dc.description.abstract Objetives: Recurrent aphthous stomatitis (RAS) is a common pathology of the oral mucosa with a complex and multifactorial etiology. Tumour Necrosis Factor-alpha (TNF?) is a cytokine with an important but not well-known role in the development of new lesions in RAS patients. Modifications of salivary levels of TNF? in RAS patients during the active periods of the disease have been measured in this work. The possible implication of TNF? in RAS etiology is also discussed. Study design: The study group was composed of 20 patients previously diagnosed with RAS and randomly selected. As a control group 10 healthy patients were also randomly selected. In both groups a TNF? assessment was carried out in non stimulated saliva. All the patients in the study group presented active lesions at the moment of the salivary sample collection. Values oscillating between 0 and 8.1 pg/ml were considered as normal. Results: Salivary TNF? levels are 2 to 5 times higher in RAS patients than those of healthy patients. Conclusions: TNF? has a possible implication in the RAS etiology and it may also have an important role in the search of new treatments for this disease. es
dc.title Salivary levels of Tumour Necrosis Factor-alpha in patients with recurrent aphthous stomatitis es
dc.type journal article es_ES
dc.subject.unesco UNESCO::CIENCIAS MÉDICAS es
dc.identifier.doi 10.4317/medoral.16.e33 es
dc.type.hasVersion VoR es_ES

Visualització       (376.6Kb)

Aquest element apareix en la col·lecció o col·leccions següent(s)

Mostra el registre parcial de l'element

Cerca a RODERIC

Cerca avançada

Visualitza

Estadístiques